OMERS Administration Corp
ALXN

OMERS Administration Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

OMERS Administration Corp’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,400
Closed -$823K – 453
2019
Q3 		$823K Buy
+8,400
New +$947K 0.01% 317

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

OMERS Administration Corp's ALXN Position: Q4 2019 in Review

OMERS Administration Corp sold out of Alexion Pharmaceuticals (ALXN) in Q4 2019, closing a stake of 8,400 shares — an estimated $823K sold.

OMERS Administration Corp first reported a position in ALXN in Q3 2019 and held it in 1 quarter. The position peaked at $823K in Q3 2019. 669 funds tracked by Wall St. Rank hold ALXN as of Q4 2019.

  • OMERS Administration Corp reported no remaining Alexion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • OMERS Administration Corp sold 8,400 Alexion Pharmaceuticals shares in Q4 2019, an estimated $823K.
  • OMERS Administration Corp first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 1 quarter.
  • OMERS Administration Corp's Alexion Pharmaceuticals position peaked at $823K in Q3 2019.
  • 669 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2019.

Based on OMERS Administration Corp's 13F filing for Q4 2019, filed 14 Feb 2020.